Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reiss

Showing results (111-120 of 269) with videos related to

Pageof 27
Sort By:
The Oncologist|September 24, 2020
Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Yu-Xiao Yang, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|September 1, 1994
Malignant eccrine neoplasms of the footM Pontone, G K Potter, S J Berlin, et al.
Cancer|April 24, 2019
A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumorsStéphanie L Gaillard, Marianna Zahurak, Anup Sharma, et al.
British Journal of Cancer|December 3, 2019
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutationMax M Wattenberg, Daniella Asch, Shun Yu, et al.
JCO Oncology Practice|March 5, 2020
Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal AdenocarcinomaErin M Bange, Abigail Doucette, Peter E Gabriel, et al.
Space Weather : the International Journal of Research & Applications|December 2, 2021
Evaluation of CME Arrival Prediction Using Ensemble Modeling Based on Heliospheric Imaging ObservationsTanja Amerstorfer, Jürgen Hinterreiter, Martin A Reiss, et al.
JCO Precision Oncology|February 1, 2022
Retrospective Survival Analysis of Patients With Resected Pancreatic Ductal Adenocarcinoma and a Germline <i>BRCA</i> or <i>PALB2</i> MutationShun Yu, Parul Agarwal, Ronac Mamtani, et al.
Molecular and Clinical Oncology|April 11, 2019
Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent?Ofer Margalit, Ronac Mamtani, Yaacov R Lawrence, et al.
Clinical Colorectal Cancer|June 19, 2018
Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction CancerSriram Venigalla, Amit K Chowdhry, Andrzej P Wojcieszynski, et al.
Journal of Genetic Counseling|June 22, 2015
"Is It Worth Knowing?" Focus Group Participants' Perceived Utility of Genomic Preconception Carrier ScreeningJennifer L Schneider, Katrina A B Goddard, James Davis, et al.
Pageof 27

Showing results (111-120 of 269) with videos related to

Sort By:
Pageof 27
The Oncologist|September 24, 2020
Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Yu-Xiao Yang, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|September 1, 1994
Malignant eccrine neoplasms of the footM Pontone, G K Potter, S J Berlin, et al.
Cancer|April 24, 2019
A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumorsStéphanie L Gaillard, Marianna Zahurak, Anup Sharma, et al.
British Journal of Cancer|December 3, 2019
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutationMax M Wattenberg, Daniella Asch, Shun Yu, et al.
JCO Oncology Practice|March 5, 2020
Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal AdenocarcinomaErin M Bange, Abigail Doucette, Peter E Gabriel, et al.
Space Weather : the International Journal of Research & Applications|December 2, 2021
Evaluation of CME Arrival Prediction Using Ensemble Modeling Based on Heliospheric Imaging ObservationsTanja Amerstorfer, Jürgen Hinterreiter, Martin A Reiss, et al.
JCO Precision Oncology|February 1, 2022
Retrospective Survival Analysis of Patients With Resected Pancreatic Ductal Adenocarcinoma and a Germline <i>BRCA</i> or <i>PALB2</i> MutationShun Yu, Parul Agarwal, Ronac Mamtani, et al.
Molecular and Clinical Oncology|April 11, 2019
Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent?Ofer Margalit, Ronac Mamtani, Yaacov R Lawrence, et al.
Clinical Colorectal Cancer|June 19, 2018
Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction CancerSriram Venigalla, Amit K Chowdhry, Andrzej P Wojcieszynski, et al.
Journal of Genetic Counseling|June 22, 2015
"Is It Worth Knowing?" Focus Group Participants' Perceived Utility of Genomic Preconception Carrier ScreeningJennifer L Schneider, Katrina A B Goddard, James Davis, et al.
Pageof 27